Cargando…
Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcoma.
Flunarizine, a diphenylpiperazine calcium channel blocker, is known to increase tumor blood flow. It also interferes with calmodulin function, repair of DNA damage and drug resistance associated with P-glycoprotein. Flunarizine was tested for its ability to modulate either cyclophosphamide- or melph...
Autores principales: | Castellino, S. M., Friedman, H. S., Elion, G. B., Ong, E. T., Marcelli, S. L., Page, R., Bigner, D. D., Dewhirst, M. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033851/ https://www.ncbi.nlm.nih.gov/pubmed/7779708 |
Ejemplares similares
-
The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment.
por: Kavanagh, B. D., et al.
Publicado: (1993) -
Cinnarizine and flunarizine as radiation sensitisers in two murine tumours.
por: Wood, P. J., et al.
Publicado: (1988) -
The effect of hyperthermia in combination with melphalan on drug-sensitive and drug-resistant CHO cells in vitro.
por: Bates, D. A., et al.
Publicado: (1990) -
Experimental re-evaluation of flunarizine as add-on antiepileptic therapy
por: Thakur, Anamika, et al.
Publicado: (2011) -
Induction of N-Ras degradation by flunarizine-mediated autophagy
por: Zheng, Ze-Yi, et al.
Publicado: (2018)